Reaching for the shower drain and finding more hair than usual is an unsettling experience at any time. On Wegovy, it can trigger immediate concern that something is wrong with the treatment or that the loss will be permanent. The reassurance most patients need is this: hair shedding on Wegovy is real, fairly common among those who experience it, almost always temporary, and not directly caused by the medication itself. Understanding what is actually happening makes it significantly easier to manage.<\/p>\n
Yes, alopecia (hair loss) appears in Wegovy’s clinical trial data and is listed as a known side effect. In the STEP trials, hair loss was reported by a meaningful subset of participants, and the rates increased at higher doses and with greater weight loss. But the mechanism behind it is not what most people assume. Wegovy does not damage hair follicles or disrupt follicle function. The hair loss is a downstream effect of the rapid weight loss the medication enables, not a direct pharmacological action of semaglutide itself.<\/p>\n
Telogen effluvium is the clinical term for the type of hair shedding most commonly seen on Wegovy. To understand it, a brief look at the hair growth cycle helps.<\/p>\n
Hair follicles cycle through three phases: anagen (active growth), catagen (transition), and telogen (resting, followed by shedding). Under normal conditions, roughly 85 to 90 percent of follicles are in the anagen phase at any given time, which is why the average person sheds only 50 to 100 hairs daily without noticing significant thinning.<\/p>\n
Significant physical stress, including rapid weight loss, major surgery, illness, or severe caloric restriction, can push a large number of follicles out of the anagen phase and into telogen simultaneously. The result is that two to four months after the triggering event, those follicles shed their hairs all at once, producing noticeably increased loss. Research on diet and nutrient deficiency has documented this pattern clearly, linking rapid weight loss and inadequate protein intake to telogen effluvium as a consistent clinical finding.<\/p>\n
The critical point is timing. Patients on Wegovy often notice shedding several months into treatment, right when the medication is producing its best results. That timing leads many to blame the drug when the actual trigger was the weight loss itself.<\/p>\n
Not everyone on Wegovy experiences significant hair loss. The majority of patients do not report it as a major concern. Among those who do, it tends to be more pronounced in patients who lose weight quickly, those at higher doses, those with pre-existing nutritional deficiencies, and those who were already experiencing some degree of thinning before starting treatment.<\/p>\n
Women, who already experience natural fluctuations in hair density with hormonal changes, may notice the shedding more acutely. Patients who were low in iron, zinc, or protein before starting Wegovy are also at higher risk because those deficiencies reduce the follicle’s resilience before the additional stress of rapid weight loss.<\/p>\n
For most patients, telogen effluvium is self-limiting. Once the triggering stress resolves or the body adapts to the new caloric intake and weight, follicles return to the anagen phase. Visible regrowth typically begins within three to six months of peak shedding, and most patients return to their prior density within a year.<\/p>\n
Consider this scenario: a patient on Wegovy notices increased shedding at month three, peaks at month four, begins to stabilize by month five, and by month eight notices new growth coming in along her hairline and temples. That trajectory is typical. The shedding is alarming in the moment but is followed by recovery in most cases.<\/p>\n
What does not resolve on its own is shedding driven by ongoing nutritional deficiencies. If protein, iron, or zinc levels remain low throughout treatment, the follicle stress continues and recovery is delayed. That is the most important modifiable factor.<\/p>\n
Protein is the primary building block of the hair shaft, and inadequate intake is one of the most consistent drivers of telogen effluvium during weight loss. Wegovy suppresses appetite significantly, which makes it easy to under-eat protein without noticing. Aiming for at least 1.0 to 1.2 grams of protein per kilogram of body weight daily, and using protein shakes or supplements when whole food intake is limited, supports follicle function during rapid weight loss. Our article on protein shakes on semaglutide<\/a> covers what to look for when appetite makes meeting protein targets through food alone difficult.<\/p>\n Iron deficiency is one of the most common nutritional deficiencies during GLP-1 treatment and one of the most direct contributors to hair shedding. Ferritin (stored iron) is the key marker to watch, and many providers do not test it routinely unless hair loss is reported. Our article on iron deficiency on semaglutide<\/a> explains why deficiency develops, how to recognize it, and what to do. If you are experiencing significant hair loss, requesting a ferritin level from your provider is one of the most useful diagnostic steps available.<\/p>\n Zinc plays a direct role in hair follicle function and cell reproduction, and it is commonly depleted during periods of reduced caloric intake. Our article on zinc supplementation on semaglutide<\/a> covers dosing considerations and when supplementation makes sense during treatment.<\/p>\n B12 and other B vitamins support hair follicle health and are worth maintaining during any period of significant dietary change. Our article on semaglutide with B12<\/a> covers why B12 is often included in compounded semaglutide formulations and what it offers independently.<\/p>\n During a period of increased shedding, mechanical stress from tight hairstyles, aggressive brushing, heat styling, and chemical treatments can worsen the appearance of loss even if they are not the underlying cause. Low-manipulation styles and gentle handling reduce the visible impact while the follicles recover.<\/p>\n Expensive topical hair loss treatments like minoxidil are designed for androgenetic alopecia (pattern hair loss), not telogen effluvium. They may offer some benefit in accelerating regrowth but will not stop the shedding triggered by weight loss stress. Biotin supplementation, often marketed for hair health, is only beneficial when there is an actual biotin deficiency, which is uncommon. Slowing your weight loss intentionally to preserve hair is generally not necessary or recommended unless shedding is extreme.<\/p>\n Hair loss is one of several physical appearance changes that come with rapid weight loss on Wegovy. Our article on how GLP-1 medications affect your skin<\/a> covers the broader landscape of skin and appearance changes during treatment, which helps put hair shedding in context alongside other normal parts of the weight loss process.<\/p>\n Hair loss on Wegovy is common enough to warrant a conversation with your provider, and temporary enough that most patients do not need to consider stopping treatment because of it. Address nutrition first, monitor key labs, and give the follicles time to recover. In most cases, the hair comes back.<\/p>\nMonitor and Address Iron Levels<\/h4>\n
Pay Attention to Zinc<\/h4>\n
Consider B12 and a Comprehensive Multivitamin<\/h4>\n
Be Gentle With Your Hair<\/h4>\n
What Probably Won’t Help<\/h3>\n
The Bigger Picture<\/h3>\n
The Bottom Line<\/h3>\n